EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Total Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹4,556 Cr | ₹4,254 Cr | ₹3,836 Cr | ₹3,424 Cr | ₹3,717 Cr |
What is the latest Total Current Assets ratio of EMCURE PHARMACEUTICALS ?
| Year | Total Current Assets |
|---|---|
| Mar2025 | ₹4,556 Cr |
| Mar2024 | ₹4,254 Cr |
| Mar2023 | ₹3,836 Cr |
| Mar2022 | ₹3,424 Cr |
| Mar2021 | ₹3,717 Cr |
How is Total Current Assets of EMCURE PHARMACEUTICALS Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,556 Cr | 7.08 | |
| Mar2024 | ₹4,254 Cr | 10.91 | |
| Mar2023 | ₹3,836 Cr | 12.03 | |
| Mar2022 | ₹3,424 Cr | -7.89 | |
| Mar2021 | ₹3,717 Cr | - | |
Compare Total Current Assets of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹27,218.0 Cr | -7.9% | 2.2% | 5.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹381,326.0 Cr | -2.8% | -7.5% | -12.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,299.0 Cr | -0.6% | -5.5% | 6.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,821.0 Cr | -2.5% | 3.5% | 21.1% | Stock Analytics | |
| CIPLA | ₹106,655.0 Cr | -3.7% | -11.7% | -8.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,861.0 Cr | -0.7% | -4.7% | -5.1% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -7.9% |
2.2% |
5.8% |
| SENSEX | 0.8% |
-2.9% |
8.1% |
You may also like the below Video Courses